Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Resolution Secretome Analysis of Chemical Hypoxia Treated Cells Identifies Putative Biomarkers of Chondrosarcoma. | Proteomes | 2022 | 35893766 | PubTator, text mining | PubMed |
| Identification and Functional Analysis of Individual-Specific Subpathways in Lung Adenocarcinoma. | Genes (Basel) | 2022 | 35885905 | PubTator, text mining | PubMed |
| A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers. | Cells | 2022 | 35883689 | PubTator, text mining | PubMed |
| Induction of Cell Cycle Arrest, Apoptosis, and Reducing the Expression of MCM Proteins in Human Lung Carcinoma A549 Cells by Cedrol, Isolated from Juniperus chinensis. | J Microbiol Biotechnol | 2022 | 35880481 | PubTator, text mining | PubMed |
| P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration. | Brain Commun | 2022 | 35865348 | PubTator, text mining | PubMed |
| A Systematic Review and Integrated Bioinformatic Analysis of Candidate Genes and Pathways in the Endometrium of Patients With Polycystic Ovary Syndrome During the Implantation Window. | Front Endocrinol (Lausanne) | 2022 | 35860699 | PubTator, text mining | PubMed |
| A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma. | Front Oncol | 2022 | 35860566 | PubTator, text mining | PubMed |
| Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer. | Front Mol Biosci | 2022 | 35847989 | PubTator, text mining | PubMed |
| BLM Sumoylation Is Required for Replication Stability and Normal Fork Velocity During DNA Replication. | Front Mol Biosci | 2022 | 35847987 | PubTator, text mining | PubMed |
| The Mechanisms of Action of Tumor Treating Fields. | Cancer Res | 2022 | 35839284 | PubTator, text mining | PubMed |
| Screening and expression verification of key genes in cutaneous squamous cell carcinoma. | Transl Cancer Res | 2022 | 35836527 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Hematopoietic transcription factor GFI1 promotes anchorage independence by sustaining ERK activity in cancer cells. | J Clin Invest | 2022 | 35819844 | PubTator, text mining | PubMed |
| Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers. | Cancer Res | 2022 | 35819252 | PubTator, text mining | PubMed |
| Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells. | Front Pharmacol | 2022 | 35814226 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35813200 | PubTator, text mining | PubMed |
| Genetically Predicted Milk Intake Increased Femoral Neck Bone Mineral Density in Women But Not in Men. | Front Endocrinol (Lausanne) | 2022 | 35795146 | PubTator, text mining | PubMed |
| Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development. | Genes Dis | 2022 | 35782979 | PubTator, text mining | PubMed |
| Rad53 arrests leading and lagging strand DNA synthesis via distinct mechanisms in response to DNA replication stress. | Bioessays | 2022 | 35778827 | PubTator, text mining | PubMed |
| Interferon-beta inhibits human glioma stem cell growth by modulating immune response and cell cycle related signaling pathways. | Cell Regen | 2022 | 35778531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=19